<DOC>
	<DOCNO>NCT00033436</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs carbogen niacinamide may make tumor cell sensitive radiation therapy . It yet know whether radiation therapy effective without carbogen niacinamide treat patient bladder cancer . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy without carbogen niacinamide treat patient locally advanced bladder cancer .</brief_summary>
	<brief_title>Radiation Therapy With Without Carbogen Niacinamide Treating Patients With Bladder Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare 6-month cystoscopic response patient locally advance transitional cell carcinoma bladder treat radical radiotherapy without radiosensitization carbogen niacinamide . - Compare local failure-free overall disease-specific survival patient treat regimen . - Compare treatment-related morbidity , particular acute chronic bowel bladder symptom , patient treat regimen . - Compare quality life patient treat regimen . OUTLINE : This randomize , multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients receive radical radiotherapy daily , 5 day week , 4-6.4 week . Patients also receive oral niacinamide daily 1.5-2 hour initiation radiotherapy dose carbogen close breathing system ( face mask tight air seal mouthpiece nasal clip ) daily begin 5 minute initiation continue completion radiotherapy dose . - Arm II : Patients receive radiotherapy arm I . Quality life assess baseline ; 4 week ; 3 , 6 , 12 month ; annually 4 year . Patients follow 8 12 week ; 6 , 9 , 12 month ; every 6 month 4 year . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : A total 330 patient ( 165 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm transitional cell carcinoma bladder Muscle invasive carcinoma ( stage T2 T3 ) grade OR Highgrade ( G3 ) superficial bladder carcinoma ( T1 ) OR Prostatic invasion ( T4a ) No squamous cell carcinoma adenocarcinoma bladder No locally advance T4b carcinoma No distant metastasis enlarge pelvic lymph node CT stag scan pelvis PATIENT CHARACTERISTICS : Age : Over 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Bilirubin great 2 time normal Renal : Creatinine great 2 time normal Cardiovascular : No ischemic heart disease peripheral vascular disease require diuretic angiotensinconverting enzyme inhibitor Pulmonary : No concurrent respiratory disease reduce respiratory drive would preclude delivery 95 % oxygen Other : Capable comply close breathe system deliver carbogen either mask mouthpiece nasal clip PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>stage I bladder cancer</keyword>
	<keyword>stage II bladder cancer</keyword>
	<keyword>stage III bladder cancer</keyword>
	<keyword>transitional cell carcinoma bladder</keyword>
</DOC>